Skip to main content

Table 1 Research timeline for each participant

From: Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial

Timepoint

D0

D1

D2

D3

D4

D5

D6

D7

D14

D15–20

D21

D22–27

D28

D90

Consent collection

x

             

Pursuit consent collection

 

x

x

x

x

x

x

x

x

x

x

x

x

 

Demographics, medical history, disease characteristics

x

             

Administration of IVIG or placebo therapy

 

x

x

x

x

         

Main outcome measurement

 

x

x

x

x

x

x

x

x

x

x

x

x

 

Collection of clinical data

x

x

x

x

x

x

x

x

x

x

x

x

x

 

Complete blood count, blood gas, creatinine

x

x

     

x

x

 

x

 

x

 

Leukocytosis, C-reactive protein, biobank collection

x

x

     

x

  

x

   

SOFA score

x

x

x

x

x

x

x

x

x

x

x

x

x

 

Adverse events

x

x

x

x

x

x

x

x

x

x

x

x

x

x

Final assessment of main outcome

            

x

 

Final assessment of secondary outcomes

            

x

x